APAna Carolina Pinto

Ana Carolina Pinto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Carolina Pinto has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Molecular drivers of intercellular communication in physical exercise: insights from omics approaches

    by Ana Carolina Pinto, Fernando Corrales, Maria Do Rosário Domingues, Helena Beatriz Ferreira, Daniel Moreira Gonçalves, Rui Vitorino, Tânia Melo, Rita Ferreira

    1. Exercise training is widely recognized as a healthy practice, being considered a non-pharmacological therapeutic approach for the management of chronic diseases such as cardiovascular diseases, ...

  • Open Access

    Deciphering the circulating lipidome signature associated with physical performance in gastric cancer patients: an exploratory study

    by Ana Carolina Pinto, Helena Beatriz Ferreira, Samuel Barbosa, Tiago Sousa, Tânia Melo, Lúcio Lara Santos, Rita Ferreira, Daniel Moreira-Gonçalves, Maria Do Rosário Domingues

    Introduction: Physical performance strongly influences peri-treatment outcomes in gastric cancer (GC), yet simple molecular markers reflecting functional status are lacking. Lipidomics may help identify circulating biomarkers linked to physical fitness. Objectives: To assess whether physical performance is associated with distinct plasma lipidomic profiles in GC patients. Methods: Nineteen male GC patients (60–75 years) from the PROTECT trial were classified as high- (HighP) or low-performance (LowP) based on the 6-min walk test. Plasma lipidomics (LC–MS/MS) quantified 232 lipid species and a total of 25 fatty acids were quantified by gas chromatography-MS. Multivariate and univariate analyses, group comparisons, and correlations examined associations with clinical, anthropometric, and fitness parameters. Results: Lipid profiles differed by performance status. HighP patients showed higher phosphatidylinositol (PI 36:2) and trends toward increased plasmalogen phosphatidylethanolamines (PE), whereas sphingomyelin (SM 43:2) was higher in LowP patients. Plasmenyl-PE species correlated positively with functional tests, muscle mass, body mass index, and nutritional status; SM 43:2 correlated negatively. Acylcarnitines showed minimal associations. Conclusion: GC patients with different physical performance status display distinct circulating lipid signatures. PI 36:2, PE plasmalogens, and SM 43:2 species appear linked to physical fitness, suggesting potential value as preoperative biomarkers. Validation in larger cohorts is warranted.